Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 14, 2013 - Issue 2
Submit an article Journal homepage
1,498
Views
0
CrossRef citations to date
0
Altmetric
Report

Report on The ALS Association's drug discovery workshop

R. RobinsonSherborn, Massachusetts
&
L. I. BrujinThe ALS Association, Washington D.C., USACorrespondence[email protected]
Pages 81-84 | Received 23 May 2012, Accepted 24 Sep 2012, Published online: 22 Oct 2012

References

  • Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem. 2011;117:528–37.
  • Volkening K, Leystra-Lantz C, Strong MJ. Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF) in humans. Amyotroph Lateral Scler. 2010;11:97–103.
  • http://www.drugs.com/nda/tafamidis_120618.htmlViewed online 26 June, 2012.
  • Wang Q, Johnson JL, Agar NY, Agar JN. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol. 2008;6:e170.
  • Swarup V, Phaneuf D, Dupré N, Petri S, Strong M, Kriz J, Julien JP. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways. J Exp Med. 2011;208:2429–47.
  • Cudkowicz M, Bozik ME, Ingersoll EW, Miller R, Mitsumoto H, Shefner J, . The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nat Med. 2011;17:1652–6.
  • Shefner J, Cedarbaum JM, Cudkowicz ME, Maragakis N, Lee J, Jones D, . Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012, May 16.
  • van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, . EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med. 2012 Aug 26. doi: 10.1038/nm.2901. (Epub ahead of print)
  • Chaddah MR, Dickie BG, Lyall D, Marshall CJ, Sykes JB, Bruijn LI. Meeting report of the International Consortium of Stem Cell Networks’ Workshop Towards Clinical Trials Using Stem Cells for Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Amyotroph Lateral Scler. 2011;12:315–7. Epub 2011, Aug 3.
  • Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, . Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A. 2012;109:5803–8. Epub 2012, Mar 26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.